Senexin C

• Description :

  Senexin C is a novel orally active and specific CDK8/19 inhibitor with potential anticancer activity.Senexin C is more metabolically stable and potent than Senexin B. Senexin C inhibits the growth of MV4-11 leukaemia cells.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  449.55

• Molecular Formula :

  C28H27N5O

• Notes :

  Research use only, not for human use.

• Receptor :

  CDK

• CAS Number :

  2375554-02-0